Sequana Medical N.V.
SEQUA.BR · BRU
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | €0 | €0 | €106 | €328 |
| % Growth | – | -100% | -67.8% | – |
| Cost of Goods Sold | €575 | €0 | €26 | €76 |
| Gross Profit | -€575 | -€0 | €79 | €252 |
| % Margin | – | – | 75.3% | 76.9% |
| R&D Expenses | €0 | €701 | €982 | €1,946 |
| G&A Expenses | €0 | €2,874 | €3,438 | €3,489 |
| SG&A Expenses | €8,391 | €8,269 | €8,834 | €12,172 |
| Sales & Mktg Exp. | €0 | €688 | €370 | €699 |
| Other Operating Expenses | €0 | €0 | €0 | €0 |
| Operating Expenses | €8,391 | €8,969 | €9,816 | €15,091 |
| Operating Income | -€8,966 | -€8,970 | -€9,737 | -€14,075 |
| % Margin | – | – | -9,229.3% | -4,291.1% |
| Other Income/Exp. Net | -€9,186 | -€24,469 | -€1,197 | -€1,814 |
| Pre-Tax Income | -€18,152 | -€33,439 | -€10,934 | -€15,889 |
| Tax Expense | €126 | €135 | €146 | €210 |
| Net Income | -€18,278 | -€33,574 | -€11,080 | -€16,100 |
| % Margin | – | – | -10,502.3% | -4,908.4% |
| EPS | -0.48 | -0.82 | -0.34 | -0.58 |
| % Growth | 41.5% | -141.2% | 41.4% | – |
| EPS Diluted | -0.48 | -0.82 | -0.34 | -0.58 |
| Weighted Avg Shares Out | 38,261 | 41,147 | 32,351 | 28,240 |
| Weighted Avg Shares Out Dil | 38,261 | 41,147 | 32,351 | 28,240 |
| Supplemental Information | – | – | – | – |
| Interest Income | €3,193 | €0 | €0 | €2,298 |
| Interest Expense | €12,763 | €1,296 | €0 | €0 |
| Depreciation & Amortization | €575 | €160 | €141 | €211 |
| EBITDA | -€4,815 | -€8,952 | -€9,454 | -€13,864 |
| % Margin | – | – | -8,960.7% | -4,226.8% |